Skip to main content
Premium Trial:

Request an Annual Quote

Going for the Gold

Graduate student Geoffrey von Maltzahn has been using gold nanoparticles to develop new methods to fight cancer. One takes advantage of the porous blood vessels that tumors put out to get gold rod-shaped nanoparticles into tumors. Once there, von Maltzahn shines a near-infrared laser on the patient's skin, above the tumor, to heat up the gold and destroy the malignant tissue. Another method developed by von Maltzahn uses two injections of nanoparticles, the first to attach to tumors and the second wave, covered with anti-cancer agents, to destroy the tumors. Because of this work, von Maltzahn is the winner of this year's Lemelson–MIT Student Prize, reports Scientific American.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.